From Supplement to Strategy: Rethinking the Clinical Application of Omega-3s and SPMs

Supporting a balanced inflammatory response is one of the most foundational pillars of integrative and functional clinical practice. This webinar will examine the nutritional science of omega-3 fatty acids — EPA and DHA — and their role in supporting the body’s natural production of Specialized Pro-Resolving Mediators (SPMs), including resolvins, protectins, and maresins.

Emerging research suggests that adequate omega-3 intake may help support the body’s resolution processes as part of a healthy inflammatory response. Participants will explore the current peer-reviewed literature and receive a science-based overview of UltraOmegaSPM, Microbiome Labs’ professional-grade omega-3 formulation designed to help support healthy EPA and DHA levels in adults.

You will learn:

-The role of EPA and DHA in supporting the body’s normal biosynthesis of Specialized Pro-Resolving Mediators (SPMs) including resolvins, protectins, and maresins and describe how these lipid mediators support the body’s natural resolution in the inflammatory process.

-What the current peer-reviewed research shows on the relationship between omega-3 fatty acid nutritional status and SPM production. Does everyone need to supplement with omeg-3 fatty acids? How can this evidence inform clinical decision-making?

-Clinical application strategies for integrating omega-3 nutritional support into patient care plans.

To watch the webinar, please register with your email to receive the recording, which you can watch at your convenience.